An ew core structure-motivated strategy for the intramolecular aromatic spiroketalization process wasf ound and used for the enantioselective synthesis of bisbenzannulated spiroketals,t he bioactive core of rubromycins,w ith high levels of enantioselectivity (up to 98% ee) via an organohalogenite-mediated asymmetric intramolecular aromatic spiroketalization. This is the first organocatalytic method for the construction of opticallyp ure bisbenzannulated spiroketals.Keywords: asymmetric synthesis; organocatalysis; organohalogen;spiroketalization Core-scaffold-lead synthesist hrough rapid construction of chiral molecular complexity around the biologically relevant framework using ah ighly efficient strategyisakey goal of organic andmedicinal synthesis.B enzannulated spiroketals,a saprivileged structural moietyf ound in al arge series of bioactive naturally occurring alkaloids andp harmaceutically relevant assays, such as Lysidicin [1] and rubromycins [2] ( Figure 1), exhibit ar ange of biological and pharmaceutical activities.[3] Although many strategies were designed to construct spiroketals [4] and related natural products, [5] the direct asymmetric catalytic approaches to access them are stillscarce.Recently,List [6] and Nagorny [7] developed the asymmetricc atalytic construction of aliphatic spiroketals by chiral phosphorica cid-catalyzed spiroketalizations (a,S cheme 1), respectively.H owever, comparedt o the asymmetric formation of aliphatic spiroketals,t he enantioselective construction of aromatic spiroketals represents ac onsiderable challenge because the aromatic hydroxy groups have less nucleophilicity.T herefore,itisnot surprising that the catalytic enantioselective synthesis of aromatics piroketals hasb een rarely